These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 21242408)

  • 41. The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial.
    Ibrahim O; Kakar R; Bolotin D; Nodzenski M; Disphanurat W; Pace N; Becker L; West DP; Poon E; Veledar E; Alam M
    J Am Acad Dermatol; 2013 Jul; 69(1):88-95. PubMed ID: 23591103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up.
    Naver H; Swartling C; Aquilonius SM
    Eur J Neurol; 2000 Jan; 7(1):55-62. PubMed ID: 10809915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis.
    Absar MS; Onwudike M
    Dermatol Surg; 2008 Jun; 34(6):751-5. PubMed ID: 18318723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety of botulinum toxin therapies.
    Madalinski MH; Slawek J
    Dis Colon Rectum; 2003 Dec; 46(12):1719-20. PubMed ID: 14668605
    [No Abstract]   [Full Text] [Related]  

  • 46. Autonomic side effects of botulinum toxin type B therapy.
    Dressler D; Benecke R
    Adv Neurol; 2004; 94():315-20. PubMed ID: 14509689
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of a transparent dressing in the treatment of axillary hyperhidrosis with botulinum toxin type A.
    Galán-Gutiérrez M; Garnacho-Saucedo G; Salido-Vallejo R; Vélez Garcia-Nieto A; Moreno-Giménez JC
    J Am Acad Dermatol; 2010 Dec; 63(6):e111-2. PubMed ID: 21093655
    [No Abstract]   [Full Text] [Related]  

  • 48. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 49. Botulinum toxin A injections in the treatment of axillary hyperhidrosis: a prospective study reviewing quality of life and patient satisfaction in a UK tertiary dermatology centre.
    Asfour L; Moussa A; Littlewood Z; Sharif J; Newsham J; O'Donoghue N; Ogden S; McMullen E; Hunter H
    Clin Exp Dermatol; 2022 Jul; 47(7):1358-1359. PubMed ID: 35262223
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of onabotulinumtoxinA and rimabotulinumtoxinB for the treatment of axillary hyperhidrosis.
    An JS; Hyun Won C; Si Han J; Park HS; Seo KK
    Dermatol Surg; 2015 Aug; 41(8):960-7. PubMed ID: 26218729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
    Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
    Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients.
    Brehmer F; Lockmann A; Grönemeyer LL; Kretschmer L; Schön MP; Thoms KM
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):799-805. PubMed ID: 26176740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis.
    Rummaneethorn P; Chalermchai T
    Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective evaluation of the efficacy of dermal botulinium toxin for primary axillary hyperhidrosis.
    Hanlon L; Cahill R; Barry MC
    Ir J Med Sci; 2006; 175(1):57-8. PubMed ID: 16615232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumescent suction curettage in the treatment of axillary hyperhidrosis: experience in 63 patients.
    Boni R
    Dermatology; 2006; 213(3):215-7. PubMed ID: 17033170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis.
    Goodman G
    Dermatol Surg; 2003 May; 29(5):533-8; discussion 538. PubMed ID: 12752524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis.
    Heckmann M; Breit S; Ceballos-Baumann A; Schaller M; Plewig G
    J Am Acad Dermatol; 1999 Dec; 41(6):987-90. PubMed ID: 10570385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum toxin for axillary hyperhidrosis.
    de Almeida AR; Montagner S
    Dermatol Clin; 2014 Oct; 32(4):495-504. PubMed ID: 25152343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Durability of botulinum toxin treatment for axillary hyperhidrosis.
    Moffat CE; Hayes WG; Nyamekye IK
    Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):188-91. PubMed ID: 19395290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
    Maillard H; Briand N; Bara C; Celerier P
    Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.